Burkitt Lymphoma
Showing 5401 - 5425 of 5,429
Cutaneous T-Cell Lymphoma Trial in Boston (bexarotene, photopheresis)
Completed
- Cutaneous T-Cell Lymphoma
- bexarotene
- photopheresis
-
Boston, MassachusettsBoston University Medical Center
Mar 23, 2006
Classical Hodgkin Lymphoma, Nodular Sclerosis, Mixed Cellularity Trial in Haifa (interim therapy scintigraphy study gallium scan
Completed
- Classical Hodgkin Lymphoma
- +4 more
- interim therapy scintigraphy study gallium scan or PET/CT
- "interim gallium or PET/CT"
-
Haifa, IsraelEldad Dann
Mar 20, 2006
Lymphoma, Non-Hodgkin Trial in United States (Recombinant Human Interleukin-2 and Rituximab)
Completed
- Lymphoma, Non-Hodgkin
- Recombinant Human Interleukin-2 and Rituximab
-
Tucson, Arizona
- +32 more
Feb 2, 2006
Lymphoma, Non-Hodgkin Trial in United States (Recombinant Human Interleukin-2 and Rituximab)
Completed
- Lymphoma, Non-Hodgkin
- Recombinant Human Interleukin-2 and Rituximab
-
Little Rock, Arkansas
- +64 more
Feb 2, 2006
Non-Hodgkin's Lymphoma, Relapsed Lymphoma, Refractory Lymphoma Trial in Berkeley Heights (gallium nitrate)
Completed
- Non-Hodgkin's Lymphoma
- +4 more
- gallium nitrate
-
Berkeley Heights, New JerseyGenta
Feb 7, 2006
Bone Marrow Angiogenesis in Acute Myeloid Leukemia - Evaluated
Unknown status
- Acute Myeloid Leukemia
-
Taipei, TaiwanTiffany Ting-Fang Shih
Feb 28, 2006
A Pathology Reference Laboratory for Study of Infectious
Unknown status
- Lymphoma
-
Zhunan Town, Miaoli County, TaiwanNational Health Research Institutes
Dec 16, 2005
Systemic Lupus Erythematosus, ANCA Associated Vasculitis Trial in Cambridge (Rituximab)
Completed
- Systemic Lupus Erythematosus
- ANCA Associated Vasculitis
-
Cambridge, Cambridgeshire, United KingdomAddenbrooke's Hospital
Feb 16, 2006
Hodgkin Disease Trial in Dresden (Combined chemo (ABVD, BACOPP-D), Radiation therapy)
Unknown status
- Hodgkin Disease
- Combined chemotherapy (ABVD, BACOPP-D)
- Radiation therapy
-
Dresden, Sachsen, GermanyMedizinische Klinik und Poliklinik I, University Clinic Carl Gus
Dec 28, 2005
Non-Hodgkin's Lymphoma Trial in Taipei (Cyclophosphamide Epirubicin Etoposide Prednisolone)
Completed
- Non-Hodgkin's Lymphoma
- Cyclophosphamide Epirubicin Etoposide Prednisolone
-
Taipei, TaiwanNational Taiwan University Hospital
Dec 5, 2005
Lymphoma, Large-Cell Trial in Sherbrooke (PET/CT 20 days after the first cycle of chemo)
Unknown status
- Lymphoma, Large-Cell
- PET/CT 20 days after the first cycle of chemotherapy
-
Sherbrooke, Quebec, CanadaCentre Hospitalier Universitaire de Sherbrooke
Nov 17, 2005
Low-Grade or Follicular B-Cell Non-Hodgkin's Lymphoma Trial in Canada, United States (rituximab)
Completed
- Low-Grade or Follicular B-Cell Non-Hodgkin's Lymphoma
-
Little Rock, Arkansas
- +30 more
Sep 13, 2005
Infections and Lymphoma in Patients Treated With TNF-a
Unknown status
- Rheumatoid Arthritis
- +3 more
- TNF-alpha antagonists
-
All Cities, FranceAll French departments of rheumatology, internal medicine, gastr
Oct 25, 2005
Molecular Mechanism of Nasopharyngeal Carcinoma
Unknown status
- Nasopharyngeal Carcinoma
-
Taipei, TaiwanNational Taiwan University College of Medicine
Sep 9, 2005
Non-Hodgkin's Lymphoma Trial in Taipei (Cyclophosphamide Doxorubicin Vincristine Lamivudine)
Completed
- Non-Hodgkin's Lymphoma
- Cyclophosphamide Doxorubicin Vincristine Lamivudine
-
Taipei, TaiwanMackay Memorial Hospital
Sep 13, 2005
Follicular Lymphoma Trial in Belgium, France (CHVP + interferon, fludarabine, CHOP + TBI and autotransplant)
Completed
- Follicular Lymphoma
- CHVP + interferon
- +2 more
-
Yvoir, Belgium
- +7 more
Aug 31, 2005
Lymphoma, Lymphoma, Non-Hodgkin, Melanoma Trial in Toronto (high frequency ultrasound imaging)
Completed
- Lymphoma
- +3 more
- high frequency ultrasound imaging
-
Toronto, Ontario, CanadaPrincess Margaret Hospital
Sep 9, 2005
Non-Hodgkin's Lymphoma Trial in New York (Iodine-131 Anti-B1 Antibody)
Unknown status
- Non-Hodgkin's Lymphoma
- Iodine-131 Anti-B1 Antibody
-
New York, New YorkCornell Medical Center
Jun 23, 2005
Lymphoma, Non-Hodgkin Trial in Ann Arbor (tumor-pulsed dendritic cells)
Completed
- Lymphoma, Non-Hodgkin
- tumor-pulsed dendritic cells
-
Ann Arbor, MichiganUniversity of Michigan Medical Center
Jun 23, 2005
Non-Hodgkin's Lymphoma Trial in United States (intravenous T900607-sodium)
Terminated
- Non-Hodgkin's Lymphoma
- intravenous T900607-sodium
-
La Jolla, California
- +4 more
Jun 23, 2005
Lymphoma, Low-Grade Trial in United States (FavId (Id-KLH) active immunotherapy)
Unknown status
- Lymphoma, Low-Grade
- FavId (Id-KLH) active immunotherapy
-
La Jolla, California
- +11 more
Jun 23, 2005
Mantle Cell Lymphoma Trial in Chicago, New York, Philadelphia (Iodine-131 Anti-B1 Antibody, Cyclophosphamide, Doxorubicin,
Completed
- Mantle Cell Lymphoma
- Iodine-131 Anti-B1 Antibody
- Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP)
-
Chicago, Illinois
- +2 more
Jun 23, 2005
Non-Hodgkin's Lymphoma Trial in United Kingdom, United States (Iodine-131 Anti-B1 Antibody)
Unknown status
- Non-Hodgkin's Lymphoma
- Iodine-131 Anti-B1 Antibody
-
Palo Alto, California
- +4 more
Jun 23, 2005